CYRX vs FDX
CYRX: Cryoport is a specialized provider of mission-critical, temperature-controlled supply chain solutions for the fast-growing cell and gene therapy market. FDX: FedEx provides comprehensive global transportation and logistics services, connecting people and possibilities through an extensive air and ground delivery network.
Side-by-side fundamentals
| Metric | CYRX | FDX | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $16.90 | $291.73 | |
| Market cap | $856M | $69.0B | |
| P/E as of 2026-10-08 | n/a | 15.74 | |
| PEG as of 2026-10-08, 3-year EPS CAGR to FY2026 | n/a | 2.53 | |
| Net margin | +44.4% | +4.7% | CYRX higher |
| Gross margin FY2025, SEC XBRL | +47.1% | n/a | |
| Operating margin | -20.9% | +5.8% | FDX higher |
| ROE | +15.6% | +14.0% | CYRX higher |
| ROA | +10.2% | +4.5% | CYRX higher |
| Debt / equity as of 2026-09-03 | 0.38 | 0.81 | CYRX lower |
| Revenue growth (YoY) as of 2026-09-03 | -8.0% | +7.7% | FDX higher |
| Revenue CAGR (3y) SEC XBRL | -9.4% | +1.7% | FDX higher |
| Dividend yield as of 2026-09-03 | n/a | +1.6% | |
| Dividend streak (yrs) SEC XBRL | 0 | 3 | FDX higher |
| Beta as of 2026-09-03 | 1.55 | 0.93 | |
| 1-year return as of 2026-10-08 close | +68.0% | +50.9% | CYRX higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.